Affordable Access

Sequential multiagent chemotherapy is not superior to high-dose cytarabine alone as postremission intensification therapy for acute myeloid leukemia in adults under 60 years of age: Cancer and Leukemia Group B Study 9222

Authors
Publisher
© 2005 by The American Society of Hematology
Publication Date
Source
PMC
Keywords
  • Clinical Observations
  • Interventions
  • And Therapeutic Trials
Disciplines
  • Medicine

Abstract

There are no comments yet on this publication. Be the first to share your thoughts.

Statistics

Seen <100 times
0 Comments